Population Pharmacokinetics of Ciprofloxacin in Neonates and Young Infants Less than Three Months of Age

Ciprofloxacin is used in neonates with suspected or documented Gram-negative serious infections. Currently, its use is off-label partly because of lack of pharmacokinetic studies. Within the FP7 EU project TINN (Treat Infection in NeoNates), our aim was to evaluate the population pharmacokinetics of...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Antimicrob Agents Chemother
Autori principali: Zhao, Wei, Hill, Helen, Le Guellec, Chantal, Neal, Tim, Mahoney, Sarah, Paulus, Stephane, Castellan, Charlotte, Kassai, Behrouz, van den Anker, Johannes N., Kearns, Gregory L., Turner, Mark A., Jacqz-Aigrain, Evelyne
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society for Microbiology 2014
Soggetti:
Pharmacology
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4249352/
https://ncbi.nlm.nih.gov/pubmed/25155587
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.03568-14
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi